← Back to Search

Focused Ultrasound

Exablate Model 4000 Type 1.0/1.1 for Essential Tremor

Waitlist Available
Research Sponsored by InSightec
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights


This trial will test if a new procedure using MR-guided focused ultrasound can be used to safely and effectively treat tremor on both sides of the brain.

Eligible Conditions
  • Essential Tremor


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Device and procedure related adverse events

Trial Design

1Treatment groups
Experimental Treatment
Group I: Exablate Secondary ProcedureExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

InSightecLead Sponsor
89 Previous Clinical Trials
3,663 Total Patients Enrolled
12 Trials studying Essential Tremor
1,017 Patients Enrolled for Essential Tremor
~10 spots leftby Jul 2025